Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
was very sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: was very sick). Rechallenge with Shingles vaccine was positive. The outcome of the sickness was not applicable. It was unknown if the reporter considered the sickness to be related to Shingles vaccine. It was unknown if the company considered the sickness to be related to Shingles vaccine. Linked case(s) involving the same patient: US2025AMR098484 Additional Information: GSK Receipt Date: 26-JUL-2025 Patient was very sick after the shot but also stated that it prevents him/her from having shingles again, so it was worth it. For tolerance of first dose refer case US2025AMR098484.; Sender's Comments: US-GSK-US2025AMR098484:first dose